BACKGROUND: The aetiology of Crohn's disease [CD] involves immune dysregulation in a genetically susceptible individual. Genome-wide association studies [GWAS] have identified 200 loci associated with CD, ulcerative colitis, or both, most of which fall within non-coding DNA regions. Long non-coding RNAs [lncRNAs] regulate gene expression by diverse mechanisms and have been associated with disease activity in inflammatory bowel disease. However, disease-associated lncRNAs have not been characterised in pathogenic immune cell populations. METHODS: Terminal ileal samples were obtained from 22 CD patients and 13 controls. RNA from lamina propria CD4+ T cells was sequenced and long intergenic non-coding RNAs [lincRNAs] were detected. Overall expression patterns, differential expression [DE], and pathway and gene enrichment analyses were performed. Knockdown of novel lincRNAs XLOC_000261 and XLOC_000014 was performed. Expression of Th1 or Th17-associated transcription factors, T-bet and RORγt, respectively, was assessed by flow cytometry. RESULTS: A total of 6402 lincRNAs were expressed, 960 of which were novel. Unsupervised clustering and principal component analysis showed that the lincRNA expression discriminated patients from controls. A total of 1792 lincRNAs were DE, and 295 [79 novel; 216 known] mapped to 267 of 5727 DE protein-coding genes. The novel lincRNAs were enriched in inflammatory and Notch signalling pathways [p <0.05]. Furthermore, DE lincRNAs in CD patients were more frequently found in DNA regions with known inflammatory bowel disease [IBD]-associated loci. The novel lincRNA XLOC_000261 negatively regulated RORγt expression in Th17 cells. CONCLUSIONS: We describe a novel set of DE lincRNAs in CD-associated CD4+ cells and demonstrate that novel lincRNA XLOC_000261 appears to negatively regulate RORγt protein expression in Th17 cells.
BACKGROUND: The aetiology of Crohn's disease [CD] involves immune dysregulation in a genetically susceptible individual. Genome-wide association studies [GWAS] have identified 200 loci associated with CD, ulcerative colitis, or both, most of which fall within non-coding DNA regions. Long non-coding RNAs [lncRNAs] regulate gene expression by diverse mechanisms and have been associated with disease activity in inflammatory bowel disease. However, disease-associated lncRNAs have not been characterised in pathogenic immune cell populations. METHODS: Terminal ileal samples were obtained from 22 CDpatients and 13 controls. RNA from lamina propria CD4+ T cells was sequenced and long intergenic non-coding RNAs [lincRNAs] were detected. Overall expression patterns, differential expression [DE], and pathway and gene enrichment analyses were performed. Knockdown of novel lincRNAs XLOC_000261 and XLOC_000014 was performed. Expression of Th1 or Th17-associated transcription factors, T-bet and RORγt, respectively, was assessed by flow cytometry. RESULTS: A total of 6402 lincRNAs were expressed, 960 of which were novel. Unsupervised clustering and principal component analysis showed that the lincRNA expression discriminated patients from controls. A total of 1792 lincRNAs were DE, and 295 [79 novel; 216 known] mapped to 267 of 5727 DE protein-coding genes. The novel lincRNAs were enriched in inflammatory and Notch signalling pathways [p <0.05]. Furthermore, DE lincRNAs in CDpatients were more frequently found in DNA regions with known inflammatory bowel disease [IBD]-associated loci. The novel lincRNA XLOC_000261 negatively regulated RORγt expression in Th17 cells. CONCLUSIONS: We describe a novel set of DE lincRNAs in CD-associated CD4+ cells and demonstrate that novel lincRNA XLOC_000261 appears to negatively regulate RORγt protein expression in Th17 cells.
Authors: D R Mathern; L E Laitman; Z Hovhannisyan; D Dunkin; S Farsio; T J Malik; G Roda; A Chitre; A C Iuga; G Yeretssian; M C Berin; S Dahan Journal: Mucosal Immunol Date: 2014-01-15 Impact factor: 7.313
Authors: Yael Haberman; Marina BenShoshan; Ayelet Di Segni; Phillip J Dexheimer; Tzipi Braun; Batia Weiss; Thomas D Walters; Robert N Baldassano; Joshua D Noe; James Markowitz; Joel Rosh; Melvin B Heyman; Anne M Griffiths; Wallace V Crandall; David R Mack; Susan S Baker; Richard Kellermayer; Ashish Patel; Anthony Otley; Steven J Steiner; Ajay S Gulati; Stephen L Guthery; Neal LeLeiko; Dedrick Moulton; Barbara S Kirschner; Scott Snapper; Camila Avivi; Iris Barshack; Maria Oliva-Hemker; Stanley A Cohen; David J Keljo; David Ziring; Yair Anikster; Bruce Aronow; Jeffrey S Hyams; Subra Kugathasan; Lee A Denson Journal: Inflamm Bowel Dis Date: 2018-01-18 Impact factor: 5.325
Authors: Olga F Sarmento; Phyllis A Svingen; Yuning Xiong; Zhifu Sun; Adebowale O Bamidele; Angela J Mathison; Thomas C Smyrk; Asha A Nair; Michelle M Gonzalez; Mary R Sagstetter; Saurabh Baheti; Dermot P B McGovern; Jessica J Friton; Konstantinos A Papadakis; Goel Gautam; Ramnik J Xavier; Raul A Urrutia; William A Faubion Journal: J Biol Chem Date: 2016-12-01 Impact factor: 5.157
Authors: Ahmad M Khalil; Mitchell Guttman; Maite Huarte; Manuel Garber; Arjun Raj; Dianali Rivea Morales; Kelly Thomas; Aviva Presser; Bradley E Bernstein; Alexander van Oudenaarden; Aviv Regev; Eric S Lander; John L Rinn Journal: Proc Natl Acad Sci U S A Date: 2009-07-01 Impact factor: 11.205
Authors: Krishna R Kalari; Asha A Nair; Jaysheel D Bhavsar; Daniel R O'Brien; Jaime I Davila; Matthew A Bockol; Jinfu Nie; Xiaojia Tang; Saurabh Baheti; Jay B Doughty; Sumit Middha; Hugues Sicotte; Aubrey E Thompson; Yan W Asmann; Jean-Pierre A Kocher Journal: BMC Bioinformatics Date: 2014-06-27 Impact factor: 3.169
Authors: Ranjit Pelia; Suresh Venkateswaran; Jason D Matthews; Yael Haberman; David J Cutler; Jeffrey S Hyams; Lee A Denson; Subra Kugathasan Journal: BMC Med Genomics Date: 2021-07-29 Impact factor: 3.063